AKT1 and metabolic disease: In the protection of IVD, ghrelin inhibits the IL‐1β‐induced NK‐κB signalling pathway to suppress metabolic disorders and apoptosis in NP cells and activates the AKT signalling pathway to stimulate the anabolism of NP cells, which in turn protects and prevents the development of degenerative disc lesions.